UBS Group’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-124
| Closed | -$155 | – | 9204 |
|
2023
Q3 | $155 | Buy |
+124
| New | +$155 | ﹤0.01% | 7629 |
|
2023
Q2 | – | Sell |
-147
| Closed | -$1.5K | – | 9041 |
|
2023
Q1 | $1.5K | Sell |
147
-127
| -46% | -$1.3K | ﹤0.01% | 7622 |
|
2022
Q4 | $4.36K | Sell |
274
-138
| -33% | -$2.2K | ﹤0.01% | 8150 |
|
2022
Q3 | $11K | Buy |
+412
| New | +$11K | ﹤0.01% | 7265 |
|
2022
Q2 | – | Sell |
-71
| Closed | -$5K | – | 10149 |
|
2022
Q1 | $5K | Buy |
+71
| New | +$5K | ﹤0.01% | 8159 |
|
2021
Q4 | – | Sell |
-66
| Closed | -$8K | – | 9665 |
|
2021
Q3 | $8K | Buy |
+66
| New | +$8K | ﹤0.01% | 7104 |
|
2020
Q3 | – | Sell |
-4
| Closed | -$1K | – | 7544 |
|
2020
Q2 | $1K | Sell |
4
-250
| -98% | -$62.5K | ﹤0.01% | 6977 |
|
2020
Q1 | $20K | Buy |
254
+152
| +149% | +$12K | ﹤0.01% | 5603 |
|
2019
Q4 | $9K | Buy |
+102
| New | +$9K | ﹤0.01% | 6284 |
|
2019
Q3 | – | Sell |
-27
| Closed | -$9K | – | 7248 |
|
2019
Q2 | $9K | Buy |
27
+12
| +80% | +$4K | ﹤0.01% | 6274 |
|
2019
Q1 | $5K | Buy |
+15
| New | +$5K | ﹤0.01% | 6365 |
|
2018
Q3 | – | Sell |
-4
| Closed | -$8K | – | 7248 |
|
2018
Q2 | $8K | Sell |
4
-7
| -64% | -$14K | ﹤0.01% | 6363 |
|
2018
Q1 | $28K | Buy |
11
+3
| +38% | +$7.64K | ﹤0.01% | 5298 |
|
2017
Q4 | $52K | Buy |
+8
| New | +$52K | ﹤0.01% | 4870 |
|
2017
Q2 | – | Hold |
0
| – | -$3K | – | 6932 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 6282 |
|
2016
Q4 | – | Hold |
0
| – | -$6K | – | 6961 |
|
2016
Q3 | – | Sell |
-1
| Closed | -$15K | – | 6149 |
|
2016
Q2 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 5647 |
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 6943 |
|
2015
Q4 | – | Hold |
0
| – | -$16K | – | 6741 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 5635 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 6853 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 6808 |
|